2019-08-07
Legal Press releases
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in compliance with GMP (Good ... Read more
2019-06-11
Legal Press releases
Intervacc AB and the Swedish University of Agricultural Sciences, SLU, have signed a multi-year contract for the development of a new generation of animal health vaccines using recombinant proteins. The contract is a ... Read more
2019-04-01
Legal Press releases
Update of previous Press Release distributed April 1, 2019: Contact information for Certified Adviser added. Otherwise no changes.
The biotechnology company Intervacc has together with 3P ... Read more
2019-04-01
Legal Press releases
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the vaccine against equine strangles. The technology transfer of ... Read more
2018-12-12
Legal Press releases
Intervacc, a Swedish innovative vaccine company listed on Nasdaq First North, has appointed Andreas Andersson as CEO. The Company thus gains a valuable addition to lead the expansion and strategic development on the ... Read more
2018-10-15
Legal Press releases